A new study offers insights into the relative efficacy of various treatments for alopecia areata (AA), suggesting that ...

In this personal essay, hairstylist and curl expert Kys Clark shares how having alopecia has redefined what beauty means to ...

Leqselvi ™ (deuruxolitinib) is now available for the treatment of adults with severe alopecia areata.

The stigma of having alopecia causes more depression and anxiety than the disease itself, new research has found.

The stigma of having alopecia causes more depression and anxiety than the disease itself, new research has found.

Leqselvi (deuruxolitinib) 8 mg tablets are approved for adults with severe alopecia areata, a disease that causes the immune system to attack hair follicles, leading to partial or complete hair loss ...

After resolving a patent dispute with Incyte, Sun Pharma has officially launched its JAK inhibitor Leqselvi in the U.S. | Sun ...

Abbvie (($CC:ABBV.CUR)) announced an update on their ongoing clinical study. AbbVie is conducting a Phase 3 clinical study ...

Prior to Olumiant, no drug was specifically approved by the FDA for alopecia areata. The traditional treatment has been monthly steroid injections.

A new drug that has gotten FDA approval may provide some relief for adults battling alopecia areata. As reported by […] The post Drug to treat alopecia gets FDA approval appeared first on TheGrio.

The FDA has approved Olumiant (baricitinib) as a treatment for alopecia areata hair loss following two randomized, double-blind, placebo-controlled trials.